Dosing & Uses
Resistant Hypertension
Pending FDA approval for resistant hypertension
Next:
Pharmacology
Mechanism of Action
Aprocitentan is an active metabolite of macitentan
Dual endothelin receptor antagonist (ERA); prevents binding of endothelin (ET)-1 to both ET-A and ET-B receptors
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
